Population pharmacokinetic analysis of the active product of dipyrone

M. Levy, M. Muszkat, B. Rich, B. Rosenkranz, P. Schlattmann*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Objective: Pharmacokinetics of 4-methyl-amino-antipyrine (MAA), the active metabolite of the nonsteroidal anti-inflammatory agent dipyrone, whose time course correlates to the therapeutic effect of the drug, are studied. Study design and setting: 153 patients hospitalized in the Department of Medicine at the Hadassah University Hospital, Jerusalem, Israel. Intervention: Patients receiving dipyrone for the treatment of fever or pain were asked to participate in the study. Pharmacokinetics and statistical analysis: Using the population approach based on a formerly developed experimental model, the relationships between pharmacokinetic parameters and demographic and physiological covariates are explored. Results: The results of the analysis show considerable variability in pharmacokinetics across the study population, and a significant decrease in clearance with age. Conclusion:Apopulation pharmacokinetic analysis of MAA, the active product of dipyrone, reveals that age is a significant predictor of MAA disposition. Covariates that measure hepatic and renal function do not appear to be good predictors of the rate of MAA disposition.

Original languageAmerican English
Pages (from-to)791-797
Number of pages7
JournalInternational Journal of Clinical Pharmacology and Therapeutics
Issue number12
StatePublished - Dec 2010
Externally publishedYes


  • Clearance
  • Dipyrone
  • MAA
  • Nonlinear mixed effects models
  • Population pharmacokinetics


Dive into the research topics of 'Population pharmacokinetic analysis of the active product of dipyrone'. Together they form a unique fingerprint.

Cite this